Strattera Does Not Require Tapering at 50mg Daily
Strattera (atomoxetine) can be discontinued abruptly at 50 mg daily without tapering. The FDA label explicitly states that "STRATTERA can be discontinued without being tapered" 1.
Evidence Supporting Abrupt Discontinuation
The FDA-approved prescribing information is unequivocal on this point—atomoxetine does not require dose tapering regardless of the dose being taken 1. This is based on prospective, placebo-controlled studies specifically designed to assess discontinuation effects.
Research confirms no discontinuation syndrome exists for atomoxetine. A prospective study of over 2,200 children and adults with ADHD who abruptly discontinued atomoxetine after 9-10 weeks of continuous therapy found 2:
- No statistically significant differences in discontinuation-emergent adverse events between those stopping atomoxetine versus those continuing placebo
- ADHD symptoms worsened after stopping but did not rebound below pretreatment levels
- No acute withdrawal syndrome developed
- Tapering is not necessary when atomoxetine is discontinued
Multiple additional studies corroborate these findings, consistently demonstrating that atomoxetine discontinuation is well tolerated without rebound effects or discontinuation syndrome 3, 4, 5.
Clinical Context: Why Atomoxetine is Different
Unlike medications that do require tapering (SSRIs, SNRIs, benzodiazepines), atomoxetine's mechanism as a selective norepinephrine reuptake inhibitor does not produce the neuroregulatory changes that lead to withdrawal symptoms 2.
While general pediatric psychopharmacology guidelines recommend slow tapering for many psychotropic medications to avoid withdrawal or rebound symptoms 6, these recommendations specifically cite examples like benzodiazepines, SSRIs, antipsychotics, and lithium—not atomoxetine.
Practical Application
At your patient's dose of 50 mg daily:
- Stop the medication immediately if discontinuation is indicated
- No dose reduction schedule is needed
- Monitor for return of ADHD symptoms over subsequent weeks (this represents the underlying condition, not withdrawal)
- Patients can miss occasional doses without concern for rebound effects 3
The only caveat: ensure the decision to discontinue is appropriate for the patient's clinical situation, as ADHD symptoms will gradually return after stopping effective treatment 1.